| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,565 |
5,697 |
$282K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,526 |
3,079 |
$238K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,539 |
1,354 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
486 |
421 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
402 |
254 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
176 |
156 |
$7K |
| 87428 |
|
101 |
98 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
84 |
72 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
69 |
69 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
163 |
156 |
$2K |
| 81002 |
|
479 |
411 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
18 |
$379.61 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
37 |
37 |
$369.30 |
| 71046 |
Radiologic examination, chest; 2 views |
33 |
23 |
$353.56 |
| 90686 |
|
24 |
24 |
$282.07 |
| 81025 |
|
48 |
38 |
$165.54 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
22 |
12 |
$1.76 |